Past Podcast Episodes

Disease-modifying therapies are the cornerstone of any effective MS treatment plan. But with more than 20 approved prescription medications available today, the choices can seem overwhelming.

People living with MS have questions — Do you start out with a safe but less effective medication, or do you hit MS hard with a high-efficacy drug that may carry more risks? When is the right time to consider switching medications, and how do you have that conversation with your neurologist? Do things like other health conditions affect which disease-modifying therapy you're on? And what about aging?

My guest is Dr. Scott Newsome, an Associate Professor of Neurology, and Director of Neurosciences Consultation and Infusion Center at Johns Hopkins Medicine. Dr. Newsome also serves as the Co-Director of the Multiple Sclerosis Experimental Therapeutics Program at Johns Hopkins.  And I'm devoting this entire episode of RealTalk MS to taking a deep-dive into disease-modifying therapies with Dr. Newsome.

One of the very few bright spots to emerge during the COVID-19 pandemic is the overall effectiveness and efficiency of telemedicine. And although people living with MS and their doctors have largely hailed telemedicine as a success, there are significant obstacles to overcome before it can become a permanent part of our healthcare system.

We have a lot to talk about! Are you ready for RealTalk MS??!

A study shows that a video game can improve cognitive function for people with MS  2:25

Researchers identify areas of the brain that are affected by fatigue  5:09

Results of the global vsMS survey remind us of all the ways that MS interrupts lives    7:04

MRI study shows one way that MS affects the brains of African-Americans differently than Caucasians  9:30

National MS Society to convene the Black MS Experience Summit  10:50

You're invited to Keep Moving Forward, a virtual benefit to celebrate the MS Movement  11:56

My Interview with Mei Wa Kwong  13:31

Share this episode  23:48

Leave a rating & review  24:09

Please Support the National MS Society COVID-19 Response Fund  24:51

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email:  https://realtalkms.com/157

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

The Center for Connected Health Policy

STUDY: A Novel In-Home Digital Treatment to Improve Processing Speed in People with Multiple Sclerosis: A Pilot Study

STUDY: Neural Mechanisms Underlying the Effects of Physical Fatigue on Effort-Based Choice

Effects of Multiple Sclerosis on Daily Activities, Emotional Well-being, and Relationships: The Global vsMS Survey

STUDY: African Americans Experience Disproportionate Neurodegenerative Changes in the Medulla and Upper Cervical Spinal Cord in Early Multiple Sclerosis

National MS Society Black MS Experience Summit

Keep Moving Forward: A Benefit to Celebrate the MS Movement

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 157
Guests: Ms. Mei Wa Kwong

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, Telehealth, vsMS, RealTalkMS